Benzer Pharmacy Selected to Dispense Purixan®

Benzer Pharmacy has been approved to dispense Purixan® as a partner for limited distribution drugs based on the pharmacy’s expertise in clinical excellence. A product of Rare Disease Therapeutics, Inc., Purixan® is the first FDA-Approved oral suspension form of mercaptopurine. Purixan® offers flexibility and accuracy of dosing, consistent absorption and is a palatable alternative to... (Read more)
340B Program Drug Pricing

340B Program Drug Pricing

The 340B program emerged in the early nineties under the Bush administration to provide a pharmaceutical purchasing reductions for specific covered entities. In essence, pharmaceutical manufacturers were asked to provide discounted drug pricing to private, non-profit or government-owned institutions where high drug costs can be detrimental to the intended public service. More specifically, children’s hospitals,... (Read more)
Benzer Pharmacy Selected for a Limited Distribution Drug, Purixan®

Benzer Pharmacy Selected for Aralast™ Distribution

Patients with Hereditary Emphysema can seek Aralast™, a limited distribution drug from America’s fastest growing independent specialty pharmacy chain. Benzer Pharmacy is now a specialty provider for Aralast™, a limited distribution drug. Aralast™ is also known as Alpha 1 proteinase inhibitor (A1PI). The drug treats patients with hereditary emphysema. Aralast™ is made from human blood... (Read more)